[A new pharmacotherapy of renal diseases].
D000293:Adolescent; D000818:Animals; D003524:Cyclosporins / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004929:Esculin / Q000627:therapeutic use; D005609:Free Radicals; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000188:drug therapy* / Q000378:metabolism; D015289:Leukotrienes / Q000378:metabolism; D016859:Lipoxygenase Inhibitors; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010100:Oxygen / Q000378:metabolism; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D012263:Ribonucleosides / Q000627:therapeutic use
D003524:Cyclosporins; D005609:Free Radicals; D007166:Immunosuppressive Agents; D015289:Leukotrienes; D016859:Lipoxygenase Inhibitors; D010975:Platelet Aggregation Inhibitors; D012263:Ribonucleosides; D004929:Esculin; C010052:mizoribine; D010100:Oxygen